 Curtis VandenBerg
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anterior Cruciate Ligament Injuries | 10 | 2026 | 218 | 2.490 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 11 | 2026 | 193 | 2.210 |
Why?
| | Femoral Fractures | 2 | 2022 | 84 | 1.210 |
Why?
| | Hip Joint | 2 | 2019 | 173 | 0.970 |
Why?
| | Fractures, Spontaneous | 1 | 2022 | 15 | 0.720 |
Why?
| | Bone Cysts | 1 | 2022 | 12 | 0.720 |
Why?
| | Hamstring Tendons | 1 | 2021 | 10 | 0.680 |
Why?
| | Fracture Fixation, Internal | 2 | 2022 | 214 | 0.650 |
Why?
| | Closed Fracture Reduction | 1 | 2019 | 8 | 0.610 |
Why?
| | Bone Neoplasms | 1 | 2022 | 259 | 0.590 |
Why?
| | Therapeutic Irrigation | 1 | 2019 | 68 | 0.590 |
Why?
| | Fracture Fixation, Intramedullary | 2 | 2020 | 60 | 0.590 |
Why?
| | Debridement | 1 | 2019 | 85 | 0.580 |
Why?
| | Fractures, Closed | 1 | 2019 | 16 | 0.570 |
Why?
| | Tibial Fractures | 1 | 2019 | 73 | 0.570 |
Why?
| | Arthritis, Infectious | 1 | 2019 | 76 | 0.550 |
Why?
| | Clinical Protocols | 2 | 2020 | 280 | 0.520 |
Why?
| | Lower Extremity | 5 | 2025 | 445 | 0.500 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 134 | 0.500 |
Why?
| | Femoracetabular Impingement | 1 | 2016 | 35 | 0.480 |
Why?
| | Knee Joint | 6 | 2023 | 428 | 0.480 |
Why?
| | Spine | 1 | 2018 | 182 | 0.480 |
Why?
| | Pubic Bone | 1 | 2014 | 6 | 0.440 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 329 | 0.430 |
Why?
| | Orthopedic Procedures | 3 | 2025 | 244 | 0.400 |
Why?
| | Patient Compliance | 1 | 2018 | 587 | 0.400 |
Why?
| | Child | 19 | 2026 | 22707 | 0.380 |
Why?
| | Range of Motion, Articular | 6 | 2025 | 429 | 0.380 |
Why?
| | Anterior Cruciate Ligament | 3 | 2023 | 101 | 0.360 |
Why?
| | Tendons | 3 | 2022 | 131 | 0.330 |
Why?
| | Patellar Ligament | 2 | 2022 | 27 | 0.320 |
Why?
| | Biomechanical Phenomena | 5 | 2021 | 857 | 0.320 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1371 | 0.320 |
Why?
| | Retrospective Studies | 13 | 2022 | 17291 | 0.310 |
Why?
| | Adolescent | 18 | 2026 | 22529 | 0.300 |
Why?
| | Postoperative Complications | 5 | 2026 | 2970 | 0.290 |
Why?
| | Tibial Meniscus Injuries | 2 | 2019 | 62 | 0.280 |
Why?
| | Athletes | 4 | 2023 | 424 | 0.280 |
Why?
| | Menisci, Tibial | 2 | 2019 | 78 | 0.280 |
Why?
| | Databases, Factual | 4 | 2026 | 1490 | 0.270 |
Why?
| | Reoperation | 2 | 2022 | 633 | 0.260 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1923 | 0.250 |
Why?
| | Exercise Test | 3 | 2020 | 630 | 0.250 |
Why?
| | Female | 23 | 2026 | 78844 | 0.240 |
Why?
| | Orthopedic Surgeons | 1 | 2025 | 30 | 0.220 |
Why?
| | Male | 20 | 2026 | 72842 | 0.210 |
Why?
| | Humans | 28 | 2026 | 145474 | 0.200 |
Why?
| | Autografts | 2 | 2021 | 55 | 0.200 |
Why?
| | Return to Sport | 3 | 2023 | 117 | 0.200 |
Why?
| | Movement | 3 | 2021 | 293 | 0.200 |
Why?
| | Cartilage, Articular | 2 | 2019 | 349 | 0.200 |
Why?
| | Nerve Block | 1 | 2025 | 107 | 0.190 |
Why?
| | Length of Stay | 2 | 2019 | 1349 | 0.190 |
Why?
| | Child, Preschool | 5 | 2022 | 11853 | 0.190 |
Why?
| | Patellofemoral Joint | 1 | 2022 | 8 | 0.180 |
Why?
| | United States | 5 | 2025 | 16098 | 0.180 |
Why?
| | Sarcoma, Synovial | 1 | 2021 | 20 | 0.170 |
Why?
| | Knee Injuries | 2 | 2019 | 122 | 0.160 |
Why?
| | Rotation | 2 | 2021 | 121 | 0.160 |
Why?
| | Salter-Harris Fractures | 1 | 2020 | 14 | 0.160 |
Why?
| | Femur | 1 | 2022 | 254 | 0.150 |
Why?
| | Humeral Fractures | 1 | 2020 | 46 | 0.150 |
Why?
| | Data Collection | 2 | 2019 | 640 | 0.150 |
Why?
| | Soft Tissue Neoplasms | 1 | 2021 | 131 | 0.150 |
Why?
| | Ankle Injuries | 1 | 2020 | 65 | 0.150 |
Why?
| | Conversion Disorder | 1 | 2019 | 10 | 0.140 |
Why?
| | Casts, Surgical | 1 | 2019 | 36 | 0.140 |
Why?
| | Bone Nails | 1 | 2019 | 61 | 0.140 |
Why?
| | Hospitals, Teaching | 1 | 2019 | 120 | 0.140 |
Why?
| | Shoulder Dislocation | 1 | 2019 | 61 | 0.140 |
Why?
| | Hospital Costs | 1 | 2019 | 125 | 0.130 |
Why?
| | Insurance Coverage | 1 | 2019 | 244 | 0.130 |
Why?
| | Upper Extremity | 1 | 2019 | 113 | 0.130 |
Why?
| | Sports | 1 | 2020 | 211 | 0.130 |
Why?
| | Risk Management | 1 | 2018 | 82 | 0.130 |
Why?
| | Blood Coagulation Disorders | 1 | 2019 | 198 | 0.130 |
Why?
| | Social Class | 1 | 2019 | 264 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2022 | 11772 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2019 | 251 | 0.120 |
Why?
| | Incidence | 2 | 2026 | 2923 | 0.120 |
Why?
| | Interleukin-1alpha | 1 | 2015 | 57 | 0.110 |
Why?
| | Odds Ratio | 1 | 2018 | 1082 | 0.110 |
Why?
| | Inpatients | 1 | 2019 | 553 | 0.110 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2014 | 28 | 0.110 |
Why?
| | Risk Factors | 3 | 2018 | 10885 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3904 | 0.110 |
Why?
| | Quality Improvement | 2 | 2026 | 1295 | 0.100 |
Why?
| | Comorbidity | 1 | 2019 | 1661 | 0.100 |
Why?
| | Tissue Engineering | 2 | 2015 | 439 | 0.100 |
Why?
| | Chondrogenesis | 1 | 2014 | 88 | 0.100 |
Why?
| | Prospective Studies | 4 | 2026 | 8057 | 0.100 |
Why?
| | Cytokines | 2 | 2015 | 2067 | 0.100 |
Why?
| | Chondrocytes | 1 | 2015 | 232 | 0.100 |
Why?
| | Athletic Injuries | 1 | 2020 | 571 | 0.100 |
Why?
| | Pelvic Bones | 1 | 2014 | 134 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2018 | 3623 | 0.090 |
Why?
| | Young Adult | 2 | 2019 | 14218 | 0.080 |
Why?
| | Infant | 2 | 2022 | 10077 | 0.080 |
Why?
| | Hospitalization | 1 | 2019 | 2460 | 0.070 |
Why?
| | Plyometric Exercise | 2 | 2018 | 6 | 0.070 |
Why?
| | Laryngectomy | 1 | 2007 | 17 | 0.060 |
Why?
| | Kinetics | 2 | 2020 | 1567 | 0.060 |
Why?
| | Salvage Therapy | 1 | 2007 | 165 | 0.060 |
Why?
| | Surgical Flaps | 1 | 2007 | 142 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2021 | 1508 | 0.060 |
Why?
| | Molybdenum | 1 | 2005 | 6 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2769 | 0.050 |
Why?
| | Tumor Burden | 1 | 2005 | 325 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2005 | 238 | 0.050 |
Why?
| | Cattle | 2 | 2015 | 946 | 0.050 |
Why?
| | Patella | 1 | 2022 | 28 | 0.050 |
Why?
| | Ligaments, Articular | 1 | 2022 | 54 | 0.040 |
Why?
| | Cadaver | 1 | 2022 | 311 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 354 | 0.040 |
Why?
| | Cohort Studies | 2 | 2023 | 6013 | 0.040 |
Why?
| | Humerus | 1 | 2020 | 40 | 0.040 |
Why?
| | Open Fracture Reduction | 1 | 2020 | 30 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 641 | 0.040 |
Why?
| | Head and Neck Neoplasms | 1 | 2005 | 561 | 0.040 |
Why?
| | Los Angeles | 1 | 2019 | 73 | 0.040 |
Why?
| | Rupture | 1 | 2019 | 91 | 0.040 |
Why?
| | Lacerations | 1 | 2019 | 40 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2019 | 1997 | 0.040 |
Why?
| | Bone Screws | 1 | 2020 | 115 | 0.040 |
Why?
| | Posture | 1 | 2020 | 197 | 0.040 |
Why?
| | Pain Management | 1 | 2023 | 410 | 0.040 |
Why?
| | Time and Motion Studies | 1 | 2018 | 28 | 0.040 |
Why?
| | Hip | 1 | 2018 | 57 | 0.030 |
Why?
| | Knee | 1 | 2018 | 72 | 0.030 |
Why?
| | Ankle | 1 | 2018 | 64 | 0.030 |
Why?
| | Patients | 1 | 2019 | 183 | 0.030 |
Why?
| | Pain | 1 | 2023 | 789 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 4148 | 0.030 |
Why?
| | Joint Instability | 1 | 2019 | 183 | 0.030 |
Why?
| | Arthroscopy | 1 | 2019 | 268 | 0.030 |
Why?
| | Registries | 1 | 2026 | 2406 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 198 | 0.030 |
Why?
| | Child Health Services | 1 | 2019 | 186 | 0.030 |
Why?
| | Pain Measurement | 1 | 2019 | 561 | 0.030 |
Why?
| | Cell Movement | 2 | 2014 | 959 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1138 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 558 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 2018 | 336 | 0.030 |
Why?
| | Quality of Life | 2 | 2023 | 3204 | 0.030 |
Why?
| | Dogs | 1 | 2015 | 458 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 1149 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5423 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 276 | 0.020 |
Why?
| | Adult | 1 | 2016 | 40777 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2865 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1845 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5904 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4560 | 0.020 |
Why?
| | Pharyngeal Diseases | 1 | 2007 | 17 | 0.020 |
Why?
| | Cutaneous Fistula | 1 | 2007 | 14 | 0.020 |
Why?
| | Laryngeal Neoplasms | 1 | 2007 | 36 | 0.020 |
Why?
| | Deglutition | 1 | 2007 | 73 | 0.020 |
Why?
| | Fistula | 1 | 2007 | 49 | 0.020 |
Why?
| | Speech | 1 | 2007 | 76 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2007 | 249 | 0.010 |
Why?
| | Animals | 3 | 2015 | 38030 | 0.010 |
Why?
| | Middle Aged | 2 | 2023 | 36215 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2005 | 185 | 0.010 |
Why?
| | Probability | 1 | 2005 | 307 | 0.010 |
Why?
| | Mice, SCID | 1 | 2005 | 369 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 546 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 286 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 886 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1048 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 848 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1716 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2524 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 874 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2005 | 1321 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5584 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3747 | 0.010 |
Why?
| | Mice | 1 | 2005 | 18329 | 0.000 |
Why?
|
|
VandenBerg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|